Solar projects are being secured under state government schemes, while an Iran-US agreement boosts investor sentiment in India. Meanwhile, an Indian pharma company faces USFDA inspection issues.
1 report, 1 independent
Updated Jun 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Solar projects are being secured under state government schemes, while an Iran-US agreement boosts investor sentiment in India. Meanwhile, an Indian pharma company faces USFDA inspection issues.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bihar
state in eastern India
-
Aurobindo Pharma
an Indian pharmaceutical company